跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Melifrin DS - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Melifrin DS
Approved
STANDARD
Melifrin DS
Lejal Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
d5855112cc8caad0
Company
Lejal Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
d5855112cc8caad0
Drug Approval Philippines Name
Melifrin DS
Product Name
Melifrin DS
Registration Number
DR-XY26812
Brand Name
Melifrin DS
Generic Name
Paracetamol
Dosage Form
Suspension
Dosage Strength
250 mg
Manufacturer
Lejal Laboratories, Inc.
Issuance Date
29 January 2024
Expiry Date
16 January 2029
Pharmacologic Category
Analgesic/Antipyretic
Classification
Over-the-Counter (OTC)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
d5855112cc8caad0
Type
Standard
Back to Philippines FDA Approvals